Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.

Barrett JR., Belij-Rammerstorfer S., Sharpe H., Makinson R., Morter R., Flaxman A., Wright D., Bellamy D., Bittaye M., Dold C., Provine NM., Aboagye J., Fowler J., Silk SE., Alderson J., Aley PK., Angus B., Berrie E., Bibi S., Cicconi P., Clutterbuck EA., Chelysheva I., Folegatti PM., Fuskova M., Jenkin D.

DOI

10.1038/s41591-021-01363-0

Type

Journal article

Journal

Nature medicine

Publisher

Springer Science and Business Media LLC

Publication Date

21/05/2021

Keywords

Oxford COVID Vaccine Trial Group

Permalink Original publication